SCHEMBL7199464

SCHEMBL7199464

CC(C)[C@H](N)C(=O)NCC(=O)NCC(N)=O

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 3/20 0.43
DPP8 Q6V1X1 3/20 0.43
DPP9 Q86TI2 3/20 0.43
DPP7 Q9UHL4 2/20 0.43
FAP Q12884 1/20 0.43
TERT O14746 2/20 0.36
SLC7A5 Q01650 1/20 0.35
MMP2 P08253 4/20 0.34
ECE1 P42892 3/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33
PTGS2 P35354 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
MALT1 Q9UDY8 1/20 0.33
METAP1 P53582 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7199462 1.00 DPP4 (0.43) DPP4DPP8DPP9DPP7FAP
SCHEMBL8819205 0.92 DPP4 (0.44) DPP4DPP8DPP9DPP7FAP
SCHEMBL26291258 0.92 DPP4 (0.44) DPP4DPP8DPP9DPP7FAP
SCHEMBL29350947 0.85 ALDH1A1 (0.50) DPP4DPP8DPP9DPP7FAP
SCHEMBL31517310 0.85 ALDH1A1 (0.50) DPP4DPP8DPP9DPP7FAP
Glycine SCHEMBL7544714 0.84 ALDH1A1 (0.40) DPP4DPP8DPP9DPP7FAP
SCHEMBL22197288 0.81 DPP4 (0.41) DPP4DPP8DPP9DPP7FAP
SCHEMBL26291257 0.81 DPP4 (0.41) DPP4DPP8DPP9DPP7FAP
SCHEMBL25015742 0.79 DPP4 (0.41) DPP4DPP8DPP9DPP7FAP
SCHEMBL10659991 0.79 SLC7A5 (0.42) TERTSLC7A5MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030050242-A1 Protein polymerization inhibitors and methods of use TRIPEP AB (SE) 2003-03-13 US disclosed
US-20020091086-A1 Peptides that block viral infectivity and methods of use thereof VAHLNE ANDERS (SE) 2002-07-11 US disclosed
EP-1207897-A2 PHARMACEUTICAL COMPOSITIONS CONTAINING TRIPEPTIDES TRIPEP AB (SE) 2002-05-29 EP disclosed
EP-1206273-A2 PEPTIDES THAT BLOCK VIRAL INFECTIVITY AND METHODS OF USE THEREOF TRIPEP AB (SE) 2002-05-22 EP disclosed
US-6258932-B1 TRIPEPTIDE OF DEFINED AMINO ACID SEQUENCE AND HAVING A C-TERMINAL AMIDE; VIRICIDES; TREATMENT AND PREVENTION OF HUMAN IMMUNODEFICIENCY VIRUS TRIPEP AB (BE) 2001-07-10 US disclosed
WO-2001010456-A2 PEPTIDES THAT BLOCK VIRAL INFECTIVITY AND METHODS OF USE THEREOF TRIPEP AB (SE) 2001-02-15 WO disclosed
WO-2001010457-A2 PHARMACEUTICAL COMPOSITIONS CONTAINING TRIPEPTIDES TRIPEP AB (SE) 2001-02-15 WO disclosed